10-Q: Precision Optics Corporation Reports Q3 2025 Results: Revenue Declines Amidst Manufacturing Challenges

Precision Optics Corporation's Q3 2025 revenue decreased by 20.2% compared to the same period last year, primarily due to lower engineering design services and finished products revenue, coupled with manufacturing yield issues.

Summary

• Precision Optics Corporation reported a decrease in revenue for the three months ended March 31, 2025, totaling $4,185,968 compared to $5,242,579 in the same period last year.
• This represents a 20.2% decrease in revenue.
• For the nine months ended March 31, 2025, revenue was $12,909,928 compared to $14,388,123 for the same period in the prior year, a decrease of 10.3%.
• Engineering Design Services revenue decreased by 59.3% for the quarter and 38.2% for the nine-month period.
• Optical Components revenue increased by 22.2% for the quarter and 27.3% for the nine-month period.
• Finished Products and Assemblies revenue decreased by 42.3% for the quarter and 44.1% for the nine-month period.
• Gross margin decreased to 10.0% for the quarter and 20.2% for the nine-month period.
• The company reported a net loss of $2,096,761 for the quarter and $4,377,689 for the nine-month period.
• Basic and fully diluted loss per share was $0.30 for the quarter and $0.67 for the nine-month period.
• The company believes that available cash, cash equivalents, cash generated from operations, availability on the line of credit, and the ability to raise funds in the capital markets will be sufficient to provide for working capital and capital expenditure requirements for at least 12 months.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to declining revenue, decreased gross margin, and a net loss. However, the company has taken steps to secure financing and manage its debt, which provides some stability.

Positives

• Optical Components revenue increased by 22.2% for the quarter and 27.3% for the nine-month period, driven by new defense/aerospace and medical device programs.
• The company successfully completed an equity raise of at least $4,500,000, satisfying a condition for a lender waiver.
• The lender agreed to waive compliance with the annual debt service coverage ratio covenant for the fiscal year ended June 30, 2025, subject to certain conditions.
• The company secured a lease extension for its El Paso, Texas facility and a new lease agreement for a facility in South Portland, Maine, indicating continued operational capacity.

Negatives

• Overall revenue decreased by 20.2% for the quarter and 10.3% for the nine-month period.
• Engineering Design Services revenue decreased significantly, by 59.3% for the quarter and 38.2% for the nine-month period.
• Finished Products and Assemblies revenue decreased by 42.3% for the quarter and 44.1% for the nine-month period.
• Gross margin decreased to 10.0% for the quarter and 20.2% for the nine-month period, driven by yield issues and lower utilization of billable engineering resources.
• The company reported a net loss of $2,096,761 for the quarter and $4,377,689 for the nine-month period.
• The company did not meet the minimum annual debt service coverage ratio covenant as of June 30, 2024, requiring a waiver from the lender.

Risks

• The company's reliance on a global supply chain makes it vulnerable to changes in U.S. tariff policy and related trade actions.
• The company faces intense competition in its markets, including from larger companies with greater resources.
• The company's future success depends on its ability to develop new optical products and services.
• The company's cash on hand and cash generated solely from operations may be insufficient to meet working capital needs, potentially requiring external financing.
• The company's loan agreement contains a minimum annual debt service coverage ratio covenant, which it has struggled to meet, requiring waivers from the lender.

Future Outlook

Management believes that the company's available cash, cash equivalents, cash generated from operations, availability on the line of credit, and the ability to raise funds in the capital markets will be sufficient to provide for the company's working capital and capital expenditure requirements for at least 12 months from the date of this filing; however, external financing may be required in the short-term.

Management Comments

• The company expects its customer pipeline to continue to expand as development projects transition to production orders and new customer projects enter the development phase.
• Current sales and marketing activities are intended to broaden awareness of the benefits of our new technology platforms and our successful application of these new technologies to medical device projects requiring surgery-grade visualization from millimeter sized devices and 3D endoscopy, including single-use products and assemblies.

Industry Context

The company operates in highly competitive markets, including medical devices and optical components, facing competition from both foreign and domestic companies, many of which are larger and have greater resources. The demand for smaller and more enhanced imaging systems is driving the market, particularly in minimally invasive surgical procedures.

Comparison to Industry Standards

• The report does not provide specific comparisons to industry standards or benchmarks.
• Without specific data on competitors' performance, it's difficult to assess Precision Optics' results relative to industry norms.
• Companies like Olympus, Stryker, and Karl Storz are major players in the medical endoscope market, and their financial performance could serve as a benchmark for Precision Optics.
• Similarly, in the optical components market, companies like Edmund Optics and Thorlabs could be considered comparables.

Stakeholder Impact

• Shareholders will be concerned about the declining revenue and net loss.
• Employees may face uncertainty due to the company's financial challenges.
• Customers may be affected by potential delays or changes in product offerings.
• Suppliers may be impacted by the company's efforts to manage costs and diversify its supply chain.
• Creditors will be monitoring the company's ability to meet its debt obligations.

Next Steps

• The company will continue to pay principal and interest under the Notes beginning with the payments due on April 15, 2025.
• The company will continue to monitor changes in costs through an analysis of purchase price variances and customer margin analysis.
• The company will work to transition development projects to production orders and secure new customer projects.
• The company will complete certain improvements to the Southborough Premises prior to occupancy.

Key Dates

Keywords

Precision Optics, Revenue, Financial Results, Optical Components, Engineering Design Services, Medical Devices, Gross Margin, Net Loss, Debt, Equity Raise